Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Napoleone Ferrara

Showing results (21-30 of 195) with videos related to

Pageof 20
Sort By:
Cancer Immunology Research|February 4, 2016
The Complex Role of Neutrophils in Tumor Angiogenesis and MetastasisWei Liang, Napoleone Ferrara
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 25, 2008
Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapiesFarbod Shojaei, Napoleone Ferrara
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 30, 2007
Antiangiogenesis to treat cancer and intraocular neovascular disordersFarbod Shojaei, Napoleone Ferrara
Cancer Research|July 18, 2008
Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cellsFarbod Shojaei, Napoleone Ferrara
Science Signaling|January 9, 2014
Inhibiting the response to VEGF in diabetesJunji Moriya, Napoleone Ferrara
Seminars in Cell & Developmental Biology|April 24, 2002
EG-VEGF and the concept of tissue-specific angiogenic growth factorsJennifer LeCouter, Napoleone Ferrara
Physiological Reviews|March 15, 2018
The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent AngiogenesisLucia Negri, Napoleone Ferrara
Cancer Journal (Sudbury, Mass.)|November 23, 2007
Antiangiogenic therapy for cancer: an updateFarbod Shojaei, Napoleone Ferrara
The Journal of Experimental Medicine|January 27, 2022
Vascular heterogeneity: VEGF receptors make blood vessels specialPin Li, Napoleone Ferrara
Nature Biotechnology|July 12, 2012
Modeling and predicting clinical efficacy for drugs targeting the tumor milieuMallika Singh, Napoleone Ferrara
Pageof 20

Showing results (21-30 of 195) with videos related to

Sort By:
Pageof 20
Cancer Immunology Research|February 4, 2016
The Complex Role of Neutrophils in Tumor Angiogenesis and MetastasisWei Liang, Napoleone Ferrara
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 25, 2008
Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapiesFarbod Shojaei, Napoleone Ferrara
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 30, 2007
Antiangiogenesis to treat cancer and intraocular neovascular disordersFarbod Shojaei, Napoleone Ferrara
Cancer Research|July 18, 2008
Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cellsFarbod Shojaei, Napoleone Ferrara
Science Signaling|January 9, 2014
Inhibiting the response to VEGF in diabetesJunji Moriya, Napoleone Ferrara
Seminars in Cell & Developmental Biology|April 24, 2002
EG-VEGF and the concept of tissue-specific angiogenic growth factorsJennifer LeCouter, Napoleone Ferrara
Physiological Reviews|March 15, 2018
The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent AngiogenesisLucia Negri, Napoleone Ferrara
Cancer Journal (Sudbury, Mass.)|November 23, 2007
Antiangiogenic therapy for cancer: an updateFarbod Shojaei, Napoleone Ferrara
The Journal of Experimental Medicine|January 27, 2022
Vascular heterogeneity: VEGF receptors make blood vessels specialPin Li, Napoleone Ferrara
Nature Biotechnology|July 12, 2012
Modeling and predicting clinical efficacy for drugs targeting the tumor milieuMallika Singh, Napoleone Ferrara
Pageof 20